ArticleNpj biosensing2025
Microfluidic nano-plasmonic imaging platform for purification- and label-free single small extracellular vesicle characterization.
Article in Npj biosensing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Extracellular vesicles in breast cancer metastasis: functional insights and advances in single-EV analysis.Cancer metastasis reviews · 2026Review
- Beyond Extracellular Vesicle (EV) Hype: Practical Solutions and Remaining Hurdles in EV Research, Manufacturing, and Clinical Translation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Tumor-derived circulating small extracellular vesicles (sEVs) are a promising class of non-invasive biomarkers for disease diagnosis. However, their quantitative detection remains challenging due to their small size and the complexity of blood plasma. Therefore, sample preparation, such as purification and fluorescence labeling, is required. This study presents a purification-free approach using a microfluidic chip integrated with PlAsmonic NanO-apeRture lAbel-free iMAging (PANORAMA) for label-free single sEV characterization in plasma. CD63, CD9, and CD81 antibodies, specific for most sEVs surface antigens, are functionalized on arrayed gold nanodisks on invisible substrates (AGNIS) for selective capture. The automated microfluidic platform minimizes operational errors and biases and enables precise control of flow rates, directions, media volume, and composition for optimization. This platform requires only 20 µL of plasma, and the analysis is completed within 60 minutes. This platform shows great potential as a sensitive and effective tool for detecting and characterizing circulating sEVs without purification or labeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.